| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |